Aceso Life Science Group Limited (HK:0474) has released an update.
Aceso Life Science Group Limited reported a significant increase in their annual loss for the fiscal year ending March 31, 2024. The company saw a decrease in revenue and faced substantial fair value losses on investment properties and financial assets. Their net loss before taxation rose sharply compared to the previous year, reflecting a challenging financial period.
For further insights into HK:0474 stock, check out TipRanks’ Stock Analysis page.
